Podcast
Author(s):
In this episode, Angela B. Smith, MD, MS, of UNC Lineberger Comprehensive Cancer Center, discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.
Phase 3 ENLIGHTED trial: Padeliporfin VTP shows promise in low-grade UTUC
Key updates from the AUA/ASRM male infertility guideline amendment
Study to assess performance of CxBladder test in urothelial carcinoma surveillance
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
UGN-102 data published in Journal of Urology as FDA weighs NMIBC approval
FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution